You are here

Cennerv Pharma withdraws IPO plans


WEAK demand for its shares has forced drug development firm Cennerv Pharmaceuticals to withdraw its application for an initial public offering (IPO), the company said last week.

The Singapore-based firm had lodged a draft prospectus for a listing on the Catalist board of...